Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on November 25, 2008
JNCI Journal of the National Cancer Institute 2008 100(23):1664-1665; doi:10.1093/jnci/djn431
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/23/1664    most recent
djn431v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Carter, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

NEWS

Learning from History: Understanding the Carcinogenic Risks of Nanotechnology

Andrea Carter

The first 10% of the full text of this article appears below.

Smaller than the average microscope can see, nanomaterials have been used in commercial products to improve industrial design and marketability for the past several years. Titanium oxide nanoparticles in sunscreen block ultraviolet rays yet allow for smooth application of the lotion and absorption into the skin. Carbon nanotubes in bicycle frames and tennis rackets make them stronger and lighter. Researchers are also using nanoparticles to direct cancer drugs to tumor tissue both in the lab and the clinic. But with these advances, some researchers have noted that the public and environmental health effects of manufacturing these materials are still unclear.

"This is not an issue to cause alarm," said . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?